Market closed
Cyclacel Pharmaceuticals/$CYCC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cyclacel Pharmaceuticals
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib.
Ticker
$CYCC
Sector
Trading on
Industry
Biotechnology
Headquarters
Kuala Lumpur, Malaysia
Employees
12
ISIN
US23254L8845
Website
CYCC Metrics
BasicAdvanced
$29M
-
-$0.04
-
-
Price and volume
Market cap
$29M
52-week high
$4.61
52-week low
$2.15
Financial strength
Current ratio
5.602
Quick ratio
5.204
Long term debt to equity
0.294
Total debt to equity
0.294
Management effectiveness
Return on assets (TTM)
-160.18%
Return on equity (TTM)
-1,950.23%
Valuation
Price to revenue (TTM)
32,835.821
Price to book
148.97
Price to tangible book (TTM)
148.97
Price to free cash flow (TTM)
-42.416
Growth
Revenue change (TTM)
-96.88%
Earnings per share change (TTM)
-99.93%
3-year earnings per share growth (CAGR)
-95.66%
CYCC News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Cyclacel Pharmaceuticals stock?
Cyclacel Pharmaceuticals (CYCC) has a market cap of $29M as of May 17, 2025.
What is the P/E ratio for Cyclacel Pharmaceuticals stock?
The price to earnings (P/E) ratio for Cyclacel Pharmaceuticals (CYCC) stock is 0 as of May 17, 2025.
Does Cyclacel Pharmaceuticals stock pay dividends?
No, Cyclacel Pharmaceuticals (CYCC) stock does not pay dividends to its shareholders as of May 17, 2025.
When is the next Cyclacel Pharmaceuticals dividend payment date?
Cyclacel Pharmaceuticals (CYCC) stock does not pay dividends to its shareholders.
What is the beta indicator for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals (CYCC) does not currently have a Beta indicator.